Dr Constantine Alifrangis, Consultant Medical Oncologist

Dr Constantine Alifrangis

Consultant Medical Oncologist

Dr Constantine Alifrangis BSc MBBS MRCP PhD

Consultant Medical Oncologist

BSc MBBS MRCP PhD

Dr Constantine Alifrangis

Consultant Medical Oncologist BSc MBBS MRCP PhD

BSc MBBS MRCP PhD
HCA-Healthcare-UK

Areas of expertise

  • Bladder cancer
  • Genito-urinary cancer
  • Penile cancer
  • Prostate cancer
  • Testicular cancer
HCA-Healthcare-UK

Address

  • LOC at Chelsea

    102 Sydney Street, Chelsea, London, SW3 6NJ

  • LOC - Leaders in Oncology Care

    95-97 Harley Street, London, W1G 6AF

  • The Prostate Centre

    18 Devonshire Street, London, W1G 7AQ

About Dr Constantine Alifrangis

GMC number: 6120950

Year qualified: 2005

Place of primary qualification: University of London

Areas of expertise

  • Bladder cancer
  • Chemotherapy
  • Genito-urinary cancer
  • Penile cancer
  • Prostate cancer
  • Testicular cancer

Professional memberships

Royal College of Physicians
General Medical Council

Articles by Dr Constantine Alifrangis

The identification of plasma exosomal mir-423-3p as a potential predictive biomarker for prostate cancer castration-resistance development by plasma exosomal mirna sequencing

Does a patient centric pathway for testicular cancer increase the uptake of cryopreservation, is it feasible and do patients come to harm? a multicentre study

Perioperative multimodality treatment in high-risk node-positive penile cancer: a single institution study of patients treated in a supraregional centre

Febrile neutropenia (fn) rates in metastatic hormone sensitive prostate cancer: the role of antibiotics as primary prophylaxis

High-sensitivity monitoring of ctdna by patient-specific sequencing panels and integration of variant reads

The use of transdermal estrogen in castrate-resistant, steroid-refractory prostate cancer